Intuitive Surgical ISRG
NASDAQ ISRG
$393.33 +9.79 (+2.55%)
At close: Sep 18, 2026 · 4:00 PM EDT

Intuitive Surgical (ISRG) Net Income towards Common Stockholders (2009 - 2026)

Intuitive Surgical (ISRG) posted Net Income towards Common Stockholders of $823.2 million for Q2 2026, little changed on a QoQ basis from $826.0 million in Q1 2026, and up 23.94% year-over-year from $664.2 million in Q2 2025.

Analysis

Intuitive Surgical (ISRG) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Intuitive Surgical has reported Net Income towards Common Stockholders for 18 years, with the latest figure at $823.2 million in Q2 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 23.94% year-over-year to $823.2 million in Q2 2026; TTM through Jun 2026 was $3.2 billion, a 20.23% increase from a year earlier, with the FY2025 full-year figure at $2.9 billion, up 23.06% from the prior year.
  • Net Income towards Common Stockholders was $823.2 million for Q2 2026 at Intuitive Surgical, roughly flat from $826.0 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $826.0 million in Q1 2026, with the low at $313.6 million in Q2 2022.
  • Average Net Income towards Common Stockholders over 5 years is $556.9 million, with a median of $559.0 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders slumped 40.04% in 2022, then soared 81.38% in 2023.
  • Over 5 years, Net Income towards Common Stockholders stood at $336.7 million in 2022, then jumped by 81.38% to $610.7 million in 2023, then increased by 12.66% to $688.0 million in 2024, then climbed by 16.21% to $799.5 million in 2025, then grew by 2.96% to $823.2 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $823.2 million (Q2 2026), $826.0 million (Q1 2026), and $799.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn 823.20 Mn
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 907.00 Mn
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn 241.40 Mn
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn 249.10 Mn
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn 383.43 Mn
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn -
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn 201.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 823.20 Mn
Mar 31, 2026 826.00 Mn
Dec 31, 2025 799.50 Mn
Sep 30, 2025 709.20 Mn
Jun 30, 2025 664.20 Mn
Mar 31, 2025 703.70 Mn
Dec 31, 2024 688.00 Mn
Sep 30, 2024 570.60 Mn
Jun 30, 2024 531.50 Mn
Mar 31, 2024 547.40 Mn
Dec 31, 2023 610.70 Mn
Sep 30, 2023 419.80 Mn
Jun 30, 2023 426.00 Mn
Mar 31, 2023 360.80 Mn
Dec 31, 2022 336.70 Mn
Sep 30, 2022 324.70 Mn
Jun 30, 2022 313.60 Mn
Mar 31, 2022 369.40 Mn
Dec 31, 2021 382.70 Mn
Sep 30, 2021 387.20 Mn